Cargando…

Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients

BACKGROUND: In hemodialysis, extracorporeal blood flow (Qb) recommendation is 300–500 mL/min. To achieve the best Qb, we based our prescription on dynamic arterial line pressure (DALP). METHODS: This prospective study included 72 patients with catheter Group 1 (G1), 1877 treatments and 35 arterio-ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Mora-Bravo, Franklin G, Mariscal, Alfonso, Herrera–Felix, Juan P, Magaña, Salvador, De-La-Cruz, Guadalupe, Flores, Nelly, Rosales, Laura, Franco, Martha, Pérez-Grovas, Héctor
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613872/
https://www.ncbi.nlm.nih.gov/pubmed/19025625
http://dx.doi.org/10.1186/1471-2369-9-15
_version_ 1782163201440350208
author Mora-Bravo, Franklin G
Mariscal, Alfonso
Herrera–Felix, Juan P
Magaña, Salvador
De-La-Cruz, Guadalupe
Flores, Nelly
Rosales, Laura
Franco, Martha
Pérez-Grovas, Héctor
author_facet Mora-Bravo, Franklin G
Mariscal, Alfonso
Herrera–Felix, Juan P
Magaña, Salvador
De-La-Cruz, Guadalupe
Flores, Nelly
Rosales, Laura
Franco, Martha
Pérez-Grovas, Héctor
author_sort Mora-Bravo, Franklin G
collection PubMed
description BACKGROUND: In hemodialysis, extracorporeal blood flow (Qb) recommendation is 300–500 mL/min. To achieve the best Qb, we based our prescription on dynamic arterial line pressure (DALP). METHODS: This prospective study included 72 patients with catheter Group 1 (G1), 1877 treatments and 35 arterio-venous (AV) fistulae Group 2 (G2), 1868 treatments. The dialysis staff was trained to prescribe Qb sufficient to obtain DALP between -200 to -250 mmHg. We measured ionic clearance (IK: mL/min), access recirculation, DALP (mmHg) and Qb (mL/min). Six prescription zones were identified: from an optimal A zone (Qb > 400, DALP -200 to -250) to zones with lower Qb E (Qb < 300, DALP -200 to -250) and F (Qb < 300, DALP > -199). RESULTS: Treatments distribution in A was 695 (37%) in G1 vs. 704 (37.7%) in G2 (P = 0.7). In B 150 (8%) in G1 vs. 458 (24.5%) in G2 (P < 0.0001). Recirculation in A was 10.0% (Inter quartile rank, IQR 6.5, 14.2) in G1 vs. 9.8% (IQR 7.5, 14.1) in G2 (P = 0.62). IK in A was 214 ± 34 (G1) vs. 213 ± 35 (G2) (P = 0.65). IK Anova between G2 zones was: A vs. C and D (P < 0.000001). Staff prescription adherence was 81.3% (G1) vs. 84.1% (G2) (P = 0.02). CONCLUSION: In conclusion, an optimal Qb can de prescribed with DALP of -200 mmHg. Staff adherence to DLAP treatment prescription could be reached up to 81.3% in catheters and 84.1% in AV fistulae.
format Text
id pubmed-2613872
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26138722009-01-06 Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients Mora-Bravo, Franklin G Mariscal, Alfonso Herrera–Felix, Juan P Magaña, Salvador De-La-Cruz, Guadalupe Flores, Nelly Rosales, Laura Franco, Martha Pérez-Grovas, Héctor BMC Nephrol Research Article BACKGROUND: In hemodialysis, extracorporeal blood flow (Qb) recommendation is 300–500 mL/min. To achieve the best Qb, we based our prescription on dynamic arterial line pressure (DALP). METHODS: This prospective study included 72 patients with catheter Group 1 (G1), 1877 treatments and 35 arterio-venous (AV) fistulae Group 2 (G2), 1868 treatments. The dialysis staff was trained to prescribe Qb sufficient to obtain DALP between -200 to -250 mmHg. We measured ionic clearance (IK: mL/min), access recirculation, DALP (mmHg) and Qb (mL/min). Six prescription zones were identified: from an optimal A zone (Qb > 400, DALP -200 to -250) to zones with lower Qb E (Qb < 300, DALP -200 to -250) and F (Qb < 300, DALP > -199). RESULTS: Treatments distribution in A was 695 (37%) in G1 vs. 704 (37.7%) in G2 (P = 0.7). In B 150 (8%) in G1 vs. 458 (24.5%) in G2 (P < 0.0001). Recirculation in A was 10.0% (Inter quartile rank, IQR 6.5, 14.2) in G1 vs. 9.8% (IQR 7.5, 14.1) in G2 (P = 0.62). IK in A was 214 ± 34 (G1) vs. 213 ± 35 (G2) (P = 0.65). IK Anova between G2 zones was: A vs. C and D (P < 0.000001). Staff prescription adherence was 81.3% (G1) vs. 84.1% (G2) (P = 0.02). CONCLUSION: In conclusion, an optimal Qb can de prescribed with DALP of -200 mmHg. Staff adherence to DLAP treatment prescription could be reached up to 81.3% in catheters and 84.1% in AV fistulae. BioMed Central 2008-11-24 /pmc/articles/PMC2613872/ /pubmed/19025625 http://dx.doi.org/10.1186/1471-2369-9-15 Text en Copyright © 2008 Mora-Bravo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mora-Bravo, Franklin G
Mariscal, Alfonso
Herrera–Felix, Juan P
Magaña, Salvador
De-La-Cruz, Guadalupe
Flores, Nelly
Rosales, Laura
Franco, Martha
Pérez-Grovas, Héctor
Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients
title Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients
title_full Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients
title_fullStr Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients
title_full_unstemmed Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients
title_short Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients
title_sort arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613872/
https://www.ncbi.nlm.nih.gov/pubmed/19025625
http://dx.doi.org/10.1186/1471-2369-9-15
work_keys_str_mv AT morabravofrankling arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients
AT mariscalalfonso arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients
AT herrerafelixjuanp arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients
AT maganasalvador arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients
AT delacruzguadalupe arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients
AT floresnelly arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients
AT rosaleslaura arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients
AT francomartha arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients
AT perezgrovashector arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients